###begin article-title 0
Pulmonary and Cardiorenal Cyclooxygenase-1 (COX-1), -2 (COX-2), and Microsomal Prostaglandin E Synthase-1 (mPGES-1) and -2 (mPGES-2) Expression in a Hypertension Model
###end article-title 0
###begin p 1
This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 377 378 377 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 97 102 <span type="species:ncbi:9606">human</span>
###xml 336 341 <span type="species:ncbi:10090">mouse</span>
###xml 351 356 <span type="species:ncbi:9606">human</span>
###xml 412 427 <span type="species:ncbi:10090">transgenic mice</span>
###xml 525 529 <span type="species:ncbi:10090">mice</span>
###xml 1805 1809 <span type="species:ncbi:10090">mice</span>
Hypertensive mice that express the human renin and angiotensinogen genes are used as a model for human hypertension because they develop hypertension secondary to increased renin-angiotensin system activity. Our study investigated the cellular localization and distribution of COX-1, COX-2, mPGES-1, and mPGES-2 in organ tissues from a mouse model of human hypertension. Male (n = 15) and female (n = 15) double transgenic mice (h-Ang 204/1 h-Ren 9) were used in the study. Lung, kidney, and heart tissues were obtained from mice at necropsy and fixed in 10% neutral buffered formalin followed by embedding in paraffin wax. Cut sections were stained immunohistochemically with antibodies to COX-1, COX-2, mPGES-1, and mPGES-2 and analyzed by light microscopy. Renal expression of COX-1 was the highest in the distal convoluted tubules, cortical collecting ducts, and medullary collecting ducts; while proximal convoluted tubules lacked COX-1 expression. Bronchial and bronchiolar epithelial cells, alveolar macrophages, and cardiac vascular endothelial cells also had strong COX-1 expression, with other renal, pulmonary, or cardiac microanatomic locations having mild-to-moderate expression. mPGES-2 expression was strong in the bronchial and bronchiolar epithelial cells, mild to moderate in various renal microanatomic locations, and absent in cardiac tissues. COX-2 expression was strong in the proximal and distal convoluted tubules, alveolar macrophages, and bronchial and bronchiolar epithelial cells. Marked mPGES-1 was present only in bronchial and bronchiolar epithelial cells; while mild-to-moderate expression was present in other pulmonary, renal, or cardiac microanatomic locations. Expression of these molecules was similar between males and females. Our work suggests that in hypertensive mice, there are (a) significant microanatomic variations in the pulmonary, renal, and cardiac distribution and cellular localization of COX-1, COX-2, mPGES-1, and mPGES-2, and (b) no differences in expression between genders.
###end p 2
###begin title 3
1. INTRODUCTION
###end title 3
###begin p 4
###xml 195 196 195 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 198 199 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 483 484 483 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 870 871 870 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
The renin-angiotensin-aldosterone system (RAAS) plays an important role in the control of cardiovascular and renal homeostasis by regulating vascular tone, blood pressure (BP), and fluid volume [1, 2]. Angiotensin II (Ang II) is a physiologically active component of the RAAS, produced via an enzymatic cascade that begins with angiotensinogen (AGT) cleaving renin (REN) to form angiotensin I (Ang I), which is then cleaved by the angiotensin converting enzyme (ACE) to form Ang II [3]. Ang II causes vasoconstriction directly by activating Ang II type 1 (AT1) receptors on vascular smooth muscle, affects fluid volume via AT1 receptor activation in the proximal tubule, resulting in renal sodium and water reabsorption, and plays an important role in the regulation of fluid balance by stimulating aldosterone secretion from the zona glomeruloza of the adrenal glands [3]. ACE inhibitors, Ang II receptor antagonists, and aldosterone receptor antagonists have been used as therapeutic interventions to treat hypertension.
###end p 4
###begin p 5
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 486 487 486 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 664 665 664 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B4">4</xref>
###xml 802 803 802 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 112 118 <span type="species:ncbi:9606">humans</span>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 329 335 <span type="species:ncbi:10090">murine</span>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
###xml 473 478 <span type="species:ncbi:9606">human</span>
###xml 496 500 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10116">rats</span>
###xml 582 587 <span type="species:ncbi:10090">mouse</span>
###xml 693 697 <span type="species:ncbi:10090">mice</span>
###xml 699 702 <span type="species:ncbi:10090">THM</span>
###xml 723 728 <span type="species:ncbi:9606">human</span>
The genes of the renin-angiotensin have been linked to and/or associated with hypertension in animal models and humans [2]. Recently, transgenic rodent models have been developed that over express both human REN and angiotensinogen, which leads to hypertension via chronic overproduction of Ang II. Specific examples include the murine double transgenic line (Ang 204/1 Ren 9), which produces a mean arterial BP 40 mmHg higher than background mice (C57Bl/6J) that lack the human genes [2]. These mice also had elevated aldosterone levels. In addition, transgenic rats harboring the mouse renin-2 gene developed hypertension, cardiac hypertrophy, and renal damage [4]. The Tsukuba hypertensive mice (THM), which express the human REN and angiotensinogen genes, have been proven to develop hypertension [5].
###end p 5
###begin p 6
###xml 473 474 473 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 616 617 616 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 619 620 619 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 731 732 731 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 734 735 734 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 726 729 <span type="species:ncbi:10090">THM</span>
Originally, the RAAS was viewed solely as an endocrine system, in which angiotensinogen of hepatic origin is secreted intothe systemic circulation and cleaved by REN and ACE to produce the active peptide Ang II. However, there is increasing evidence that suggests a RAAS may reside within several organs or tissues, including kidney, lung, heart, and vascular smoothmuscle cells (SMC), where it is believed to act in a functionally independent paracrine/autocrine fashion [6]. This hypothesis is further supported by the fact that all components of the RAAS in the heart, kidney, and lung contain the ACE component [3, 6]. Additionally, high concentrations of Ang II have been demonstrated in the plasma, heart, and kidney of THM [7, 8].
###end p 6
###begin p 7
###xml 132 133 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 793 795 793 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
In the kidney, prostaglandins (PGs) are important mediators of hemodynamic regulation, salt and water homeostasis, and REN release [9, 10]. The main PG in the kidney is PGE2, which is synthesized from arachidonic acid (AA) by enzymatic reactions, particularly cyclooxygenases and prostaglandin E synthases (PGES). Cyclooxygenase (COX) derived PGs have two distinct membrane-anchored isoenzymes, COX-1 and COX-2. COX-1 is constitutively expressed and found in most normal body tissues, while COX-2 is expressed in normal tissues at low levels and is highly induced by proinflammatory mediators in inflammation, injury, and pain settings [9]. The membrane-associated PGES-1 (mPGES-1) is inducible and functionally linked to COX-2, while mPGES-2 is constitutive and coupled to both COX isoforms [11].
###end p 7
###begin p 8
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 95 97 95 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 103 106 <span type="species:ncbi:10090">THM</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 319 323 <span type="species:ncbi:10116">rats</span>
###xml 463 467 <span type="species:ncbi:10116">rats</span>
It has been suggested that regulation of COX-2 in the kidney is altered by the RAAS system [9, 12]. In THM mice, increased expression of COX-2 in the macula densa has been reported [13], and an important role for RAAS in cardiac hypertrophy has been noted [14]. In addition, activation of RAAS has been demonstrated in rats with heart failure [6]. Overexpression of COX-2 has also been observed in the aldosterone-treated animals in normotensive and hypertensive rats [15].
###end p 8
###begin p 9
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 79 83 <span type="species:ncbi:10090">mice</span>
In the lung, significant reduction in BP was seen in PG EP1 receptor-deficient mice and was accompanied by increased REN-Ang activity [16]. In addition, plasma Ang II levels were raised in severe asthma [17].
###end p 9
###begin p 10
###xml 145 160 <span type="species:ncbi:10090">transgenic mice</span>
###xml 372 387 <span type="species:ncbi:10090">transgenic mice</span>
###xml 525 530 <span type="species:ncbi:9606">human</span>
There are currently no published reports on the cellular expression and microanatomic location of COX-1, COX-2, mPGES-1, mPGES-2 in hypertensive transgenic mice. Therefore, using immunohistochemistry, we investigated the microanatomic location and cellular expression of COX-1, COX-2, mPGES-1, mPGES-2 in kidney, lung, and heart tissues obtained from renin-angiotensingen transgenic mice. This study is the first to report on the pulmonary and Cardiorenal microanatomic expression of these molecules in this animal model for human hypertension.
###end p 10
###begin title 11
2. MATERIALS AND METHODS
###end title 11
###begin title 12
2.1. Animals
###end title 12
###begin p 13
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 60 75 <span type="species:ncbi:10090">transgenic mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 192 197 <span type="species:ncbi:9606">human</span>
###xml 253 258 <span type="species:ncbi:9606">human</span>
###xml 419 423 <span type="species:ncbi:10090">mice</span>
###xml 439 444 <span type="species:ncbi:9606">human</span>
15- to 20-week-old male (n = 15) and female (n = 15) double transgenic mice (h-Ang 204/1 h-Ren 9) were used in the study. The mice were derived from a founder colony of 5 male mice expressing human angiotensinogen (h-Ang 204/1) and 6 females expressing human renin (h-Ren6), obtained from Dr. Curt Sigmund at the University of Iowa, School of Medicine. At Charles River Laboratories (Wilmington, Massachusetts), female mice that expressed human REN were bred with angiotensinogen-expressing males to produce the double transgenic line. The transgenic line was developed on a C57/BI6J background. All the procedures were in compliance with the Pfizer Ann Arbor Laboratories Animal Care and Use Committee.
###end p 13
###begin title 14
2.2. Study tissue samples
###end title 14
###begin p 15
###xml 181 183 181 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
Lung, kidney, and heart tissues were obtained from the mice at the time of necropsy. Tissues were fixed in 10% neutral buffered formalin for 24 hours and embedded in paraffin wax. 3mum-thick sections were then cut and stained immunohistochemically with antibodies to COX-1, COX-2, mPGES-1, and mPGES-2.
###end p 15
###begin title 16
2.3. Immunohistochemistry for COX-1, COX-2, mPGES-1, and mPGES-2
###end title 16
###begin p 17
###xml 66 68 66 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
To analyze the expression of COX-1, COX-2, mPGES-1, and mPGES-2, 3mum sections were cut from formalin-fixed, paraffin-embedded blocks, mounted on positively charged glass slides, dried, and then loaded on the automated immunostainer (room temperature using a Ventana Discovery (Ventana Medical Systems, Tucson, AZ). Slides were deparaffinized and then rehydrated. Sections were incubated for 30 minutes with serum free DakoCytomation protein blocker (Dako Corporation, Dako, CA) and then rinsed and incubated for 4 minutes with Avidin-Biotin blocking solution (Ventana Medical Systems). Antigen retrieval was completed with a Ventana specialty solution (8 = pH) (Ventana Medical Systems).
###end p 17
###begin p 18
###xml 35 37 35 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 257 259 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 486 488 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#956;</italic>
###xml 285 291 <span type="species:ncbi:9986">rabbit</span>
###xml 965 971 <span type="species:ncbi:9986">rabbit</span>
Automation included exposure to 100muL of primary anti-COX-1 (1:200), COX-2 (1:20), mPGES-1 (1:750), or mPGES-2 (1:1000) antibody (Cayman Chemical, Ann Arbor, MI) diluted with reagent diluent (Ventana Medical Systems) at room temperature for 60 minutes. 100muL of the appropriate anti-rabbit biotinylated IgG linking solution (Vector Laboratories) was applied to each section at 1:200 dilution for 60 minutes at room temperature. Sections were again rinsed and allowed to react with 100muL of diaminobenzidine (DAB detection kit) substrate solution (Ventana Medical Systems) for 8 minutes, followed by counterstaining with Hematoxylin and then Bluing Reagent for 4 minutes each, removed from the autostainer, washed in warm water, dehydrated through graded alcohol, cleared in xylene, and cover slipped. Control reactions included (1) sections incubated with the omission of primary antibody and processed as mentioned above, and (2) sections incubated with normal rabbit serum instead of the primary antibody and processed as above.
###end p 18
###begin title 19
3. RESULTS
###end title 19
###begin p 20
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">1</xref>
###xml 133 134 133 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">2</xref>
###xml 136 137 136 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">3</xref>
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">4</xref>
The pulmonary and Cardiorenal cellular expression and distribution of COX-1, COX-2, mPGES-1, and mPGES-2 are summarized in Tables 1, 2, 3, and 4. Staining intensity ranged from negative (-) to strong (+++).
###end p 20
###begin p 21
###xml 236 247 236 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1(a)</xref>
###xml 252 259 252 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
In the kidney, strong diffuse cytoplasmic COX-1 expression occurred in the distal convoluted tubules (DCT), cortical collecting ducts, and medullary collecting ducts, while proximal convoluted tubules (PCT) lacked COX-1 expression (see Figure 1(a) and Table 1). Moderate (++) diffuse COX-1 cytoplasmic staining was present in vascular endothelial cells (EC) and SMC, cortical interstitial cells (IC), the glomerular visceral epithelium, and the capsular parietal epithelium. Mild (+) COX-1 expression was present in medullary IC, glomerular podocytes, and the medullary ascending limb (MAL). Expression of COX-1 was equivocal in the macula densa.
###end p 21
###begin p 22
###xml 371 382 371 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1(b)</xref>
###xml 387 394 387 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
In the lungs and heart, COX-1 was strongly expressed in alveolar macrophages, the bronchial and bronchiolar epithelium, and cardiac vascular endothelial cells, but moderately expressed in alveolar septa, bronchial smooth muscle cells, pulmonary vascular endothelial cells, pulmonary vascular EC, and cardiac vascular SMC. COX-1 was not expressed in cardiac myocytes (see Figure 1(b) and Table 2).
###end p 22
###begin p 23
###xml 146 157 146 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2(a)</xref>
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
mPGES-2 was expressed in the kidney at a moderate diffuse level in PCT and DCT, capsular parietal epithelium, and medullary collecting ducts (see Figure 2(a) and Table 1). Mild expression was present in macula densa, vascular SMC and EC, glomerular podocytes and the visceral epithelium, cortical collecting ducts, and the MAL. No mPGES-2 expression was present in cortical or medullary IC.
###end p 23
###begin p 24
###xml 116 127 116 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2(b)</xref>
###xml 132 139 132 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
Pulmonary expression of mPGES-2 included strong diffuse staining in bronchial and bronchiolar epithelial cells (see Figure 2(b) and Table 2), moderate staining in alveolar macrophages and septa, mild staining in bronchial SMC, and pulmonary vascular EC and SMC. No mPGES-2 expression was present in any of the cardiac microanatomic locations examined.
###end p 24
###begin p 25
###xml 58 69 58 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3(a)</xref>
###xml 74 81 74 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
Renal COX-2 expression was strong in the PCT and DCT (see Figure 3(a) and Table 3), moderate in macula densa, vascular SMC and EC, and medullary collecting ducts, and mild in cortical and medullary interstitial cells, cortical collecting ducts, and the MAL. No expression was present in glomeruli or the capsular (parietal) epithelium.
###end p 25
###begin p 26
###xml 130 141 130 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3(b)</xref>
###xml 146 153 146 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
In the lung, marked (+++) COX-2 expression was present in alveolar macrophages, and the bronchial and bronchiolar epithelium (see Figure 3(b) and Table 4). Other pulmonary microanatomic locations had mild or equivocal COX-2 expression. Cardiac vascular EC had mild COX-2 expression, while cardiac myocytes and cardiac vascular SMC were negative.
###end p 26
###begin p 27
###xml 121 132 121 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4(a)</xref>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
For mPGES-1, expression was mild in renal vascular SMC and EC, cortical and medullary collecting ducts, and the MAL (see Figure 4(a) and Table 3). Expression in the macula densa, glomerular (visceral) epithelium, and capsular (parietal) epithelium was equivocal. No mPGES-1 expression was present in other microanatomic renal locations.
###end p 27
###begin p 28
###xml 75 86 75 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4(b)</xref>
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
mPGES-1 was the highest in bronchial and bronchiolar epithelial cells (see Figure 4(b) and Table 4). Moderate expression was present in bronchial SMC. Mild expression was present in alveolar macrophages and alveolar septa, while expression in pulmonary vascular EC and SMC was equivocal. Mild mPGES-1 expression was present in cardiac vascular EC and cardiac vascular SMC, while other cardiac microanatomic locations lacked expression. The expression of all these molecules was similar between males and females.
###end p 28
###begin title 29
4. DISCUSSION
###end title 29
###begin p 30
###xml 310 311 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 319 320 319 320 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
PGs are modulators of physiological functions and contribute to REN release, regulation of renal microvascular hemodynamics, salt balance, and BP controlvia mechanisms involving the regulation of vascular tone and renal excretory function. The kidney is capable of synthesizing all types of PGs, especially PGE2 and PGI2, which influence urinary sodium excretion directly through inhibition of the tubulartransport function and indirectly through the regulation of renin-angiotensin system activity [18]. COX, a rate-limiting enzyme in the PG biosynthesispathway, exists in two major isoforms: the constitutive COX-1 and the inducible COX-2 [19]. COX-1 is expressed constitutively at varying levels in the majority of tissues and generally plays a role in tissue homeostasis.
###end p 30
###begin p 31
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 495 497 495 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 726 728 726 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 730 732 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 734 736 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 591 594 <span type="species:ncbi:9913">cow</span>
###xml 596 599 <span type="species:ncbi:9615">dog</span>
###xml 601 611 <span type="species:ncbi:10141">guinea pig</span>
###xml 613 618 <span type="species:ncbi:9606">human</span>
###xml 628 633 <span type="species:ncbi:10090">mouse</span>
###xml 635 641 <span type="species:ncbi:9986">rabbit</span>
###xml 643 646 <span type="species:ncbi:10116">rat</span>
###xml 652 657 <span type="species:ncbi:9940">sheep</span>
In this study, the highest degree of renal COX-1 expression occurred in the DCT, cortical collecting ducts, and medullary collecting ducts, while mild-to-moderate COX-1 expression occurred in other microanatomic renal locations. PCT lacked COX-1 expression. These results are concurrent with COX-1 being the most abundant COX isoform that is constitutively expressed in the kidney and regionally localized in the renal vasculature, collecting ducts, and papillary IC across various species [20, 21]. Further evidence supporting these results includes previous work in which various species (cow, dog, guinea pig, human, monkey, mouse, rabbit, rat, and sheep) exhibited high levels of COX-1 expression in the collecting ducts [20, 22, 23].
###end p 31
###begin p 32
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 149 155 <span type="species:ncbi:9606">humans</span>
###xml 220 224 <span type="species:ncbi:10090">mice</span>
###xml 473 477 <span type="species:ncbi:10116">rats</span>
Since COX-1 is expressed in the collecting ducts of the nephron, an active area in the regulation of sodium excretion in both laboratory animals and humans [24], it is not surprising that BP increases in COX-1 deficient mice compared with wild-type controls [25]. Nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) may aggravate renin-independent, sodium-sensitive hypertension, possibly in part by inhibition of the COX-1 responsible for sodium excretion [26]. In rats infused with selective COX inhibitors, NS-398 or meloxicam, direct renal interstitial volume expansion significantly increased renal interstitial hydrostatic pressure and fractional excretion of sodium [27].
###end p 32
###begin p 33
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 225 229 <span type="species:ncbi:9823">pigs</span>
###xml 231 235 <span type="species:ncbi:10116">rats</span>
###xml 237 242 <span type="species:ncbi:9940">sheep</span>
###xml 248 254 <span type="species:ncbi:9606">humans</span>
###xml 444 447 <span type="species:ncbi:9615">dog</span>
Our finding that most cardiac microanatomic locations had COX-1 expression with the exception of cardiac myocytes is consistent with other studies showing COX-1 expression in both EC and SMC of the fetal ductus arteriosus of pigs, rats, sheep, and humans [28-31]. Furthermore, COX-1 was constitutively expressed in the EC of the aorta and microvasculature, fibrous connective tissue of the tricuspid valve, and chordae tendinae of the heart of dog [32].
###end p 33
###begin p 34
###xml 138 140 138 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 244 246 244 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 125 130 <span type="species:ncbi:9606">human</span>
###xml 239 242 <span type="species:ncbi:10116">rat</span>
All pulmonary microanatomic locations had COX-1 expression in our study. Other examples of COX-1 expression in lungs include human lungs [33], and the bronchiolar epithelium and smooth muscle, alveolar macrophages, EC, and vascular SMC of rat [34]. As a result, COX-1-dependent prostanoid generation has been implicated in the regulation of bronchial tone [34].
###end p 34
###begin p 35
###xml 128 129 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 165 167 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 520 522 520 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 506 511 <span type="species:ncbi:10090">mouse</span>
mPGES-2 is constitutively expressed in several tissues, is not induced during inflammation, and has been proposed to mediate PGE2 production from both COX isoforms [11, 35]. In our study, moderate mPGES-2 expression was present in PCT and DCT, the capsular parietal epithelium, and medullary collecting ducts, while mild or no expression was present in other renal microanatomic locations. In other studies, high expression of mPGES was reported in distal tubules, and medullary collecting ducts in normal mouse kidney [36]. mPGES-2 was expressed in all pulmonary microstructures examined.
###end p 35
###begin p 36
###xml 228 230 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
In the heart, mPGES-2 was not present in any microanatomic locations. Other studies using primary cultures of neonatal ventricular myocytes have shown that mPGES-2 is constitutively synthesized in myocytes and is not regulated [37].
###end p 36
###begin p 37
###xml 79 81 79 81 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 898 900 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 902 904 902 904 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 977 979 977 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 447 452 <span type="species:ncbi:9606">human</span>
###xml 850 854 <span type="species:ncbi:10116">rats</span>
###xml 934 938 <span type="species:ncbi:10090">mice</span>
COX-2 is expressed in variable locations in the kidney across various species [20]. COX-2 deficient mice exhibited severe disruption of renal development and function, suggesting an important role for COX-2 in renal development [38, 39]. The normal rodent and canine kidney have prominent constitutive COX-2 expression in the macula densa and thick ascending limb of loop of Henle, whereas COX-2 is absent at these sites in the normal primate and human kidney [21]. In our study, COX-2 was present in all microanatomic renal locations, with the exception of the glomeruli and capsular (parietal) epithelium. This finding is consistent with the known regulatory association between COX-2 and REN reported by Schnermann [40]. Demonstration that indomethacin and SC58236 (a selective COX-2 inhibitor) can decrease BP and suppress plasma REN activity in rats lends further support to this association [41, 42]. Conversely, COX-2 knockout mice had reduced REN content and activity [43].
###end p 37
###begin p 38
###xml 345 347 345 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
The marked increase of COX-2 expression in the pulmonary epithelium in our study is consistent with the known role of respiratory epithelia as a first line of defense. Pulmonary epithelial cells have an important role in airway homeostasis, perform many important biological functions, and represent the first line of defense against infection [44]. Activation of the renin-angiotensin system has also been demonstrated in acute asthma [17].
###end p 38
###begin p 39
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
Cardiac vascular EC and SMC had COX-2 expression, while no expression was present in cardiac myocytes or SMC in our study. Ang II is known to stimulate vascular SMC growth [45]. An important role for Ang II in the regulation of COX-2 has been reported [46].
###end p 39
###begin p 40
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 58 60 58 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 548 550 548 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 404 412 <span type="species:ncbi:9606">patients</span>
mPGES-1 is a source of inducible PGE2 synthetic activity [47]. In this study, mPGES-1 was present in renal vascular EC and SMC, cortical and medullary collecting ducts, MAL, all pulmonary microanatomic locations, and cardiac vascular EC and SMC, while no expression was present in other renal or cardiac microanatomic locations. These findings are consistent with increased mPGES expression described in patients with hyperprostaglandin E syndrome [48]. mPGES-1 was also induced by the proinflammatory cytokine in cardiac myocytes and fibroblasts [37].
###end p 40
###begin p 41
###xml 31 35 <span type="species:ncbi:10090">mice</span>
In conclusion, in hypertensive mice there are (a) significant microanatomic variations in the pulmonary, renal, and cardiac distribution and cellular localization of mPGES-1, mPGES-2, COX-1, and COX-2 and (b) no differences in expression between genders.
###end p 41
###begin title 42
ACKNOWLEDGMENTS
###end title 42
###begin p 43
###xml 99 114 <span type="species:ncbi:10090">transgenic mice</span>
The authors thank Dr. Curt Sigmund at The School of Medicine, University of Iowa for providing the transgenic mice colony and Jamie Phillips for her technical assistance.
###end p 43
###begin article-title 44
Eplerenone: cardiovascular protection
###end article-title 44
###begin article-title 45
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 65 80 <span type="species:ncbi:10090">transgenic mice</span>
Regulation of human renin mRNA expression and protein release in transgenic mice
###end article-title 45
###begin article-title 46
Minireview: overview of the renin-angiotensin system-an endocrine and paracrine system
###end article-title 46
###begin article-title 47
###xml 62 65 <span type="species:ncbi:10116">rat</span>
Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27
###end article-title 47
###begin article-title 48
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 58 63 <span type="species:ncbi:9606">human</span>
###xml 120 125 <span type="species:ncbi:9606">human</span>
The Tsukuba hypertensive mouse (transgenic mouse carrying human genes for both renin and angiotensinogen) as a model of human malignant hypertension: development of lesions and morphometric analysis
###end article-title 48
###begin article-title 49
###xml 86 90 <span type="species:ncbi:10116">rats</span>
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure
###end article-title 49
###begin article-title 50
###xml 87 102 <span type="species:ncbi:10090">transgenic mice</span>
###xml 117 122 <span type="species:ncbi:9606">human</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes
###end article-title 50
###begin article-title 51
###xml 96 100 <span type="species:ncbi:10090">mice</span>
Tissue angiotensin II concentration in the heart and kidneys in transgenic Tsukuba hypertensive mice
###end article-title 51
###begin article-title 52
Interactions between COX-2 and the renin-angiotensin system in the kidney
###end article-title 52
###begin article-title 53
Physiological regulation of cyclooxygenase-2 in the kidney
###end article-title 53
###begin article-title 54
Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney
###end article-title 54
###begin article-title 55
Cyclooxygenase-2 and the renal renin-angiotensin system
###end article-title 55
###begin article-title 56
###xml 109 114 <span type="species:ncbi:10090">mouse</span>
Renin, cyclooxygenase-2 and neuronal nitric oxide synthase in the kidneys of transgenic Tsukuba hypertensive mouse
###end article-title 56
###begin article-title 57
###xml 118 122 <span type="species:ncbi:10090">mice</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
Role of the renin-angiotensin system in cardiac hypertrophy and renal glomerular sclerosis in transgenic hypertensive mice carrying both human renin and angiotensinogen genes
###end article-title 57
###begin article-title 58
###xml 113 117 <span type="species:ncbi:10116">rats</span>
Participation of prostacyclin in endothelial dysfunction induced by aldosterone in normotensive and hypertensive rats
###end article-title 58
###begin article-title 59
###xml 19 20 19 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The prostaglandin E2 EP1 receptor mediates pain perception and regulates blood pressure
###end article-title 59
###begin article-title 60
Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function
###end article-title 60
###begin article-title 61
Functional and molecular aspects of renal prostaglandin receptors
###end article-title 61
###begin article-title 62
Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2
###end article-title 62
###begin article-title 63
Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity
###end article-title 63
###begin article-title 64
Interspecies differences in the nephrotoxic response to cyclooxygenase inhibition
###end article-title 64
###begin article-title 65
###xml 90 93 <span type="species:ncbi:10116">rat</span>
###xml 95 100 <span type="species:ncbi:10090">mouse</span>
Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse)
###end article-title 65
###begin article-title 66
Immunohistochemical localization of the prostaglandin-forming cyclooxygenase in renal cortex
###end article-title 66
###begin article-title 67
Renal arachidonic acid metabolism
###end article-title 67
###begin article-title 68
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Cyclooxygenase-1-deficient mice have high sleep-to-wake blood pressure ratios and renal vasoconstriction
###end article-title 68
###begin article-title 69
Cyclooxygenase-2 inhibitors attenuate increased blood pressure in renovascular hypertensive models, but not in deoxycorticosterone-salt hypertension
###end article-title 69
###begin article-title 70
Natriuretic response to increased pressure is preserved with COX-2 inhibitors
###end article-title 70
###begin article-title 71
Cyclooxygenase-2 plays a significant role in regulating the tone of the fetal lamb ductus arteriosus
###end article-title 71
###begin article-title 72
###xml 72 76 <span type="species:ncbi:9823">pigs</span>
Expression of cyclooxygenases in ductus arteriosus of fetal and newborn pigs
###end article-title 72
###begin article-title 73
###xml 20 25 <span type="species:ncbi:9606">human</span>
Cyclooxygenase-2 in human pathological disease
###end article-title 73
###begin article-title 74
Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy
###end article-title 74
###begin article-title 75
###xml 69 73 <span type="species:ncbi:9615">dogs</span>
Localization of cyclooxygenase isozymes in cardiovascular tissues of dogs treated with naproxen
###end article-title 75
###begin article-title 76
Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma
###end article-title 76
###begin article-title 77
###xml 61 64 <span type="species:ncbi:10116">rat</span>
Cyclooxygenase isoenzyme localization and mRNA expression in rat lungs
###end article-title 77
###begin article-title 78
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2
###end article-title 78
###begin article-title 79
###xml 70 71 70 71 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
Urogenital distribution of a mouse membrane-associated prostaglandin E2 synthase
###end article-title 79
###begin article-title 80
Regulation of the membrane-localized prostaglandin E synthases mPGES-1 and mPGES-2 in cardiac myocytes and fibroblasts
###end article-title 80
###begin article-title 81
###xml 60 64 <span type="species:ncbi:10090">mice</span>
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
###end article-title 81
###begin article-title 82
###xml 78 83 <span type="species:ncbi:10090">mouse</span>
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
###end article-title 82
###begin article-title 83
Cyclooxygenase-2 and macula densa control of renin secretion
###end article-title 83
###begin article-title 84
###xml 76 80 <span type="species:ncbi:10116">rats</span>
Indomethacin decreases arterial blood pressure and plasma renin activity in rats with aortic ligation
###end article-title 84
###begin article-title 85
Cyclooxygenase-2 inhibition decreases renin content and lowers blood pressure in a model of renovascular hypertension
###end article-title 85
###begin article-title 86
###xml 35 39 <span type="species:ncbi:10090">mice</span>
Renin expression in COX-2-knockout mice on normal or low-salt diets
###end article-title 86
###begin article-title 87
Airway epithelial cells as regulators of airway inflammation (review)
###end article-title 87
###begin article-title 88
Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia
###end article-title 88
###begin article-title 89
Cyclooxygenase 2 and the kidney
###end article-title 89
###begin article-title 90
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Microsomal prostaglandin E synthase-1: the inducible synthase for prostaglandin E2
###end article-title 90
###begin article-title 91
###xml 39 40 39 40 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 73 81 <span type="species:ncbi:9606">children</span>
Induction of microsomal prostaglandin E2 synthase in the macula densa in children with hypokalemic salt-losing tubulopathies
###end article-title 91
###begin p 92
Renal immunohistochemical expression of mPGES-2 and COX-1. PCT = proximal convoluted tubules; DCT = distal convoluted tubules; SMC = smooth muscle cells; EC = endothelial cells; IC = interstitial cells; MAL = medullary ascending limb.
###end p 92
###begin p 93
(+/-) = equivocal staining; (-) = no staining, (+) = mild staining; (++) = moderate staining; (+++) = strong staining.
###end p 93
###begin p 94
Pulmonary and cardiac immunohistochemical expression of mPGES-2 and COX-1. SMC = smooth muscle cells; EC = endothelial cells.
###end p 94
###begin p 95
(-) = no staining; (+) = mild staining; (++) = moderate staining; (+++) = strong staining.
###end p 95
###begin p 96
Renal immunohistochemical expression of mPGES-1 and COX-2. PCT = proximal convoluted tubules; DCT = distal convoluted tubules; SMC = smooth muscle cells; EC = endothelial cells; IC = interstitial cells; MAL = medullary ascending limb.
###end p 96
###begin p 97
(+/-) = equivocal staining; (-) = no staining; (+) = mild staining; (++) = moderate staining; (+++) = strong staining.
###end p 97
###begin p 98
Pulmonary and cardiac immunohistochemical expression of mPGES-1 and COX-2. EC = endothelial cells; SMC = smooth muscle cells.
###end p 98
###begin p 99
(+/-) = equivocal staining; (-) = no staining; (+) = mild staining; (++) = moderate staining; (+++) = strong staining.
###end p 99

